Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD Anderson's clinical and ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer. The ...

HOUSTON, JANUARY 22, 2026 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

At The University of Texas MD Anderson Cancer Center, our mission has always been clear: to end cancer. Achieving this goal requires more than just groundbreaking research and exceptional patient care ...

Naval Daver, MD, who leads a number of acute myeloid leukemia (AML) research trials at MD Anderson Cancer Center in Houston, looks forward to a future where the treatment for AML is truly personalized ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...